Korean J Med > Volume 80(3); 2011 > Article |
|
WHO/ISH risk category |
p-value | |||
---|---|---|---|---|
Low risk (n = 100) |
Medium risk (n = 229) |
High risk (n = 314) |
||
Age, yr | 51.3 ± 11.2 | 54.8 ± 11.2 | 59.1 ± 12.4 | <0.001 |
Men, n (%) | 52 (52.0) | 104 (45.4) | 165 (52.5) | 0.235 |
Cardiovascular risk factors, n (%) | 0.6 ± 0.8 | 1.2 ± 0.7 | 1.6 ± 1.0 | <0.001 |
Age above 55 or 65 yearsa) | 0 (0.0) | 86 (37.6) | 163 (51.9) | <0.001 |
Smoking | 0 (0.0) | 43 (18.8) | 65 (22.9) | 0.021 |
Hypercholesterolemiab) | 0 (0.0) | 34 (14.8) | 64 (20.4) | 0.072 |
Low HDL cholesterolc) | 0 (0.0) | 42 (18.3) | 103 (32.8) | <0.001 |
Family historyd) | 0 (0.0) | 73 (31.9) | 93 (29.6) | <0.001 |
Obesitye) | 0 (0.0) | 16 (7.0) | 29 (9.2) | 0.006 |
Comorbidity, n (%) | ||||
Diabetes | 0 (0.0) | 0 (0.0) | 112 (35.7) | <0.001 |
Cerebrovascular disease | 0 (0.0) | 0 (0.0) | 60 (19.1) | <0.001 |
Renal disease | 0 (0.0) | 0 (0.0) | 32 (10.2) | <0.001 |
Peripheral vascular disease | 0 (0.0) | 0 (0) | 2 (0.6) | 0.046 |
Target organ damage, n (%) | ||||
LVH | 0 (0.0) | 0 (0.0) | 105 (33.4) | <0.001 |
Microalbuminuria | 0 (0.0) | 0 (0.0) | 76 (24) | <0.001 |
Atherosclerotic plaque | 0 (0.0) | 0 (0.0) | 22 (7.0) | 0.114 |
Hypertensive retinopathy G-III/IV | 0 (0.0) | 0 (0.0) | 21 (6.7) | 0.002 |
Controlled (n = 498) | Uncontrolled (n = 145) | p-value | |
---|---|---|---|
Men, n (%) | 244 (49.0) | 77 (53.1) | 0.384 |
WHO/ISH risk | < 0.001 | ||
Low | 89 (17.9) t | 11 (7.6) | |
Intermediate | 195 (39.2) | 34 (23.4) | |
High | 214 (43.0) | 100 (69.0) | |
Initial SBP, mmHg | < 0.001 | ||
Below 150 | 139 (27.9) | 11 (7.6) | |
151~159 | 176 (35.3) | 54 (37.2) | |
Above 160 | 183 (36.7) | 80 (55.2) | |
Initial DBP, mmHg | 0.003 | ||
Below 95 | 319 (64.0) | 78 (53.8) | |
96~99 | 87 (17.5) | 20 (13.6) | |
Above 100 | 92 (18.5) | 47 (32.1) | |
Smoking, n (%) | 89 (17.9) | 26 (17.9) | 0.987 |
Hypercholesterolemiaa), n (%) | 78 (15.7) | 20 (13.8) | 0.118 |
Family history of CVDb), n (%) | 140 (28.1) | 26 (17.9) | 0.014 |
Obesityc), n (%) | 39 (7.8) | 6 (4.1) | 0.125 |
Diabetes | 69 (13.9) | 43 (29.7) | < 0.001 |
CVD | 41 (8.2) | 19 (13.1) | 0.156 |
Renal disease | 12 (2.4) | 20 (13.8) | < 0.001 |
Peripheral vascular disease | 1 (0.2) | 1 (0.6) | 0.644 |
No. of initial drugs, n (%) | 0.025 | ||
Single | 239 (48.0) | 52 (35.9) | |
Dual | 158 (31.7) | 61 (42.1) | |
>Triple | 101 (20.3) | 32 (22.1) |